WaveMan
WaveMan · Company
ARXS · Arxis, Inc.
> Search tickers & screens ⌘K
LIVE
← All companies

ARXS Arxis (ARXS) Insider Trading, Ownership & Congress Trades

Aerospace & Defense · Aircraft parts & auxiliary equipment, nec · CIK 0002093536
SEC filings
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
141
13F, latest reported quarter

Arxis insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

No insider purchases or sales are on record for Arxis, Inc. in the period covered. Source: SEC Form 4 filings, as of 2026-10-28.

Insider
Filed
Shares
Value
Since filing
Chief Accounting Officer
BUY
2026-04-20 SECtraded 2026-04-17
4,464
$125.0K
+39.4%
Context
  • First Form 4 purchase or sale (code P or S) here by this insider on our record.
  • The trade is 8.7% of the 51,331 shares held after it.
  • 6 other insiders bought within 30 days.
  • 141 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Accounting Officer Jankowski Ryan Anthony bought about $125.0K of ARXS on Apr 17, 2026, the largest insider purchase at the company on our record; 6 other insiders bought within 30 days and 141 funds added in the latest 13F quarter.
BUY
2026-04-20 SECtraded 2026-04-17
36,000
$1.0M
+39.4%
Context
  • First Form 4 purchase or sale (code P or S) here by this insider on our record.
  • The trade is 8.9% of the 403,864 shares held after it.
  • 6 other insiders bought within 30 days.
  • 141 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: See Remarks Badakhsh Azad Sid bought about $1.0M of ARXS on Apr 17, 2026, the largest insider purchase at the company on our record; 6 other insiders bought within 30 days and 141 funds added in the latest 13F quarter.
BUY
2026-04-20 SECtraded 2026-04-17
12,500
$350.0K
+39.4%
Context
  • First Form 4 purchase or sale (code P or S) here by this insider on our record.
  • The trade is 1.1% of the 1,102,807 shares held after it.
  • 6 other insiders bought within 30 days.
  • 141 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: See Remarks Sealfon Ross Bradley bought about $350.0K of ARXS on Apr 17, 2026, the largest insider purchase at the company on our record; 6 other insiders bought within 30 days and 141 funds added in the latest 13F quarter.
BUY
2026-04-20 SECtraded 2026-04-17
25,000
$700.0K
+39.4%
Context
  • First Form 4 purchase or sale (code P or S) here by this insider on our record.
  • The trade is 82.4% of the 30,357 shares held after it.
  • 6 other insiders bought within 30 days.
  • 141 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Oetgen Stephen Duane bought about $700.0K of ARXS on Apr 17, 2026, the largest insider purchase at the company on our record; 6 other insiders bought within 30 days and 141 funds added in the latest 13F quarter.
BUY
2026-04-20 SECtraded 2026-04-17
10,000
$280.0K
+39.4%
Context
  • First Form 4 purchase or sale (code P or S) here by this insider on our record.
  • The trade is 65.1% of the 15,357 shares held after it.
  • 6 other insiders bought within 30 days.
  • 141 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director ALLEN PATRICK E bought about $280.0K of ARXS on Apr 17, 2026, the largest insider purchase at the company on our record; 6 other insiders bought within 30 days and 141 funds added in the latest 13F quarter.
7 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Showing the latest few. to see 2 more transactions and use the screener and CSV export. We store only your email; there is no password.
Seven facts, ranked against the sector · Rank is not a forecast
Insiders
no insider buys or sells on file
Congress
no House purchase disclosed in the last 12 months
Funds
141 funds bought in last quarter
below 58% of Aerospace & Defense
Revenue
+114.1% year over year
more than 90% of Aerospace & Defense
Margin
2.9% net margin
more than 54% of Aerospace & Defense
Buybacks
$2.0M repurchased, FY to 2025-12-31
below 93% of Aerospace & Defense
Short interest
7.7% of the float short (float per yahoo 2026-10-26) · 4.5 days to cover · settled 2026-09-30
What changed in the last 30 days
Nothing new filed in the last 30 days

Watch ARXS

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+35.8%12M
-12%+10%+32%+55%2026-042026-052026-062026-072026-082026-092026-10 2026-04-17 · Roth Jason Aaron bought $1.7M2026-04-17 · Perhamus Kevin Scott bought $1.5M2026-04-17 · Badakhsh Azad Sid bought $1.0M2026-04-17 · Oetgen Stephen Duane bought $700.0K2026-04-17 · Sealfon Ross Bradley bought $350.0K2026-04-17 · ALLEN PATRICK E bought $280.0K2026-04-17 · Jankowski Ryan Anthony bought $125.0K
Insider buy
Indexed to 100, dividend-adjusted, not a price chart. When a name files heavily, the largest trades are drawn first.

Who owns ARXS: institutional holders (13F)

13F holdings, latest reported quarter
4,516,959 sh
$208.4M
$122.6M
2,196,658 sh
$101.4M

Congress trades in ARXS

No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.

Activist and 5% holders (13D/13G)

No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.

ARXS planned insider sales (Form 144)

No planned-sale notices
No insider has filed to sell. Watch this after a run-up.

ARXS mutual fund holders (N-PORT)

Funds ranked by the share of their own portfolio in this stock (N-PORT).
ALGER WEATHERBIE SPECIALIZED GROWTH FUND
$6.2M position · as of 2026-07-31
2.6%
Capital Group U.S. Large Growth ETF
$2.0M position · as of 2026-05-31
2.4%
GRANDEUR PEAK US STALWARTS FUND
$339.0K position · as of 2026-07-31
2.0%
Janus Henderson Contrarian Fund
$89.4M position · as of 2026-06-30
1.6%
BARON DISCOVERY FUND
$27.9M position · as of 2026-06-30
1.5%
Baron SMID Cap ETF
$492.2K position · as of 2026-06-30
1.5%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M · % is the share of the fund's own portfolio
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows 141 funds added last quarter. Each figure is a federal filing, dated the day it went public.
Same sector, ranked by filing activity
Sector by SEC SIC code

ARXS financials

Revenue growth
+114.1%
XBRL, annual
Net margin
2.9%
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
2025-122024-122023-12
Revenue$1.6B$743.0M$424.5M
Gross profit$754.7M$331.1M$194.0M
Operating income$276.7M$102.6M$54.3M
Net income$46.0M-$55.5M-$59.9M
Operating cash flow$251.2M$70.9M-$7.9M
Cash$250.3M$110.8Mn/a
Long-term debt$2.6B$2.5Bn/a
Buybacks$2.0M$0$0
SEC XBRL, fiscal years, as known on 2026-10-28

ARXS Stock Sonar score 3/7 axes

Find similar shapesCompare

ARXS ranks highest on growth (90th percentile) and risk and compliance (70th), and lowest on institutional and government (42nd), among Aerospace & Defense peers.

Growth
90
Inputs
  • Revenue growth, YoY+114.1% · 90 pct, sector of 51
  • Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Institutional and government
42
Inputs
  • Funds adding, latest quarter141 · 42 pct, sector of 53
  • Congress net buyers, 365dno Congress trades in 365 days
  • Federal contracts, 180dno federal contracts in 180 days
  • Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
70
Inputs
  • Short interest, % of float+7.7% · 40 pct, sector of 61
  • Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
  • EPA cases per $1B revenue, 5y0.00 per $1B · 100 pct, sector of 38
  • New text in Risk Factors, latest 10-Kneeds two 10-Ks with a Risk Factors section (not 20-F filers or stubs)
4 not measured: Profitability, Financial health, Insider conviction, US patents
  • Profitability needs 2 of 4 inputs, 0 present: fewer than four consecutive quarters of net income; fewer than four consecutive quarters of operating income
  • Financial health needs 1 of 2 inputs, 0 present: needs four quarters of operating cash flow; no equity line filed
  • Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

3 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing